Clinical Trials Browser

Enrolling by invitation × Multiple Myeloma × Clear all

NCT05332054 2026-03-12

LTFS

Enrolling by invitation

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT07410403 2026-02-13

AI

Enrolling by invitation

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02473757 2025-12-01

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

Enrolling by invitation

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, B-Cell, Hematologic Neoplasms

NCT07210047 2025-10-07

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

Phase 1/2 Enrolling by invitation

Multiple Myeloma

NCT03628612 2025-08-07

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

Phase 2 Enrolling by invitation

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, T-Cell

NCT05775224 2024-06-17

ASH Research Collaborative Data Hub

Enrolling by invitation

100,000 enrolled

Classical hematologyPlasma cell

Anemia, Sickle Cell, Multiple Myeloma, Neoplasms, Plasma Cell

NCT03815279 2019-08-16

iStopMM

Phase 2 Enrolling by invitation

Smoldering Multiple Myeloma, Multiple Myeloma